Login / Signup

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur.

Jennifer SwainsonAlexander McGirrPierre BlierElisa BrietzkeStéphane Richard-DevantoyNisha RavindranJean BlierSerge BeaulieuBenicio N FreySidney H KennedyRoger S McIntyreRoumen V MilevSagar V ParikhAyal SchafferValerie H TaylorValérie TourjmanMichael van AmeringenLakshmi N YathamArun V RavindranRaymond W Lam
Published in: Canadian journal of psychiatry. Revue canadienne de psychiatrie (2020)
Single-dose IV racemic ketamine is a third-line recommendation for adults with TRD. The need for repeated and maintenance ketamine infusions should be carefully assessed on a case-by-case basis with consideration of potential risks and benefits. Because of limited evidence for efficacy and risk for misuse and diversion, the use of oral and other formulations of racemic ketamine should be limited to specialists with ketamine-prescribing expertise and affiliations with tertiary or specialized centers.
Keyphrases